Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Renal guidance: Dual Blockade of the Renin-Angiotensin System (RAS)
For adult hypertension with CrCl 30 mL/min or less, the recommended first oral enalapril dose is 2.5 mg once daily. Above 30, the usual initial regimen applies. Dialysis days, heart failure, baseline hypotension and diuretic use have separate considerations.
RDM74-vasotec-official-1 · Source locator: Renal guidance: Dual Blockade of the Renin-Angiotensin System (RAS)
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.
